182 related articles for article (PubMed ID: 19240692)
1. High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment.
Balani P; Boulaire J; Zhao Y; Zeng J; Lin J; Wang S
Mol Ther; 2009 Jun; 17(6):1003-11. PubMed ID: 19240692
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy.
Wu C; Lin J; Hong M; Choudhury Y; Balani P; Leung D; Dang LH; Zhao Y; Zeng J; Wang S
Mol Ther; 2009 Dec; 17(12):2058-66. PubMed ID: 19809402
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
4. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
5. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.
Yawata T; Maeda Y; Okiku M; Ishida E; Ikenaka K; Shimizu K
J Neurooncol; 2011 Sep; 104(2):497-507. PubMed ID: 21347689
[TBL] [Abstract][Full Text] [Related]
7. INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.
Wang HW; Breslin MB; Chen C; Akerstrom V; Zhong Q; Lan MS
Hum Gene Ther; 2009 Nov; 20(11):1308-18. PubMed ID: 19604042
[TBL] [Abstract][Full Text] [Related]
8. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect.
Tamura R; Miyoshi H; Morimoto Y; Oishi Y; Sampetrean O; Iwasawa C; Mine Y; Saya H; Yoshida K; Okano H; Toda M
Hum Gene Ther; 2020 Mar; 31(5-6):352-366. PubMed ID: 32075424
[TBL] [Abstract][Full Text] [Related]
9. Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.
Ardiani A; Sanchez-Bonilla M; Black ME
Cancer Gene Ther; 2010 Feb; 17(2):86-96. PubMed ID: 19763147
[TBL] [Abstract][Full Text] [Related]
10. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.
Liu C; Wen C; Wang X; Wei Y; Xu C; Mu X; Zhang L; Wang X; Tian J; Ma P; Meng F; Zhang Q; Zhao N; Yu B; Gong T; Guo R; Wang H; Xie J; Sun G; Li G; Zhang H; Qin Q; Xu J; Dong X; Wang L
Exp Cell Res; 2019 Oct; 383(1):111496. PubMed ID: 31306654
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated double suicide gene selectively kills gastric cancer cells.
Luo XR; Li JS; Niu Y; Miao L
Asian Pac J Cancer Prev; 2012; 13(3):781-4. PubMed ID: 22631647
[TBL] [Abstract][Full Text] [Related]
12. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
13. Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression.
Kia A; Przystal JM; Nianiaris N; Mazarakis ND; Mintz PJ; Hajitou A
Mol Cancer Ther; 2012 Dec; 11(12):2566-77. PubMed ID: 23053496
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
15. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
Oh B; Han J; Choi E; Tan X; Lee M
J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
[TBL] [Abstract][Full Text] [Related]
16. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
Kim HA; Park JH; Yi N; Lee M
Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
[TBL] [Abstract][Full Text] [Related]
18. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
19. Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors.
Wang C; Ma Y; Hu Q; Xie T; Wu J; Zeng F; Song F
BMC Cancer; 2016 Jul; 16():545. PubMed ID: 27464624
[TBL] [Abstract][Full Text] [Related]
20. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]